Pygeum
Prunus africana · Pygeum africanum · African plum tree
Snapshot
| Indications | Contraindications |
|---|---|
Pygeum is an extract of the bark of Prunus africana, the African plum tree, traditionally used for lower urinary tract symptoms of benign prostatic hyperplasia (BPH)8. Laboratory work links it to androgen receptor blockade and reduced inflammatory mediator production8. The typical user is an older man with BPH-related frequency, nocturia, and weak flow.8 It is also taken in combination products for hair loss and for sexual performance, a use with no scientific support8.
Human research is limited to about seven small trials, mostly in urinary symptoms of BPH, with one in hair loss. A Cochrane review found improved urinary symptoms and flow measures versus placebo, though trials were short, used varied preparations, and did not compare against standard BPH medications1. Later reviews remain split: one found inadequate outcome reporting to recommend it, and another did not recommend phytotherapy for BPH9, 10. In a 2026 in vitro study, Prunus africana bark extract was selectively cytotoxic to hormonally insensitive prostate cancer cells; no human trial has tested it. Products are sold as bark extract or powder and in combination formulas with saw palmetto and pumpkin seed; see Form comparison.
Health Canada labels ask for practitioner consultation before use to exclude prostate cancer, since BPH-type urinary symptoms can have other causes6. The European Medicines Agency herbal monograph for traditional use asks for a doctor's review if fever, blood in the urine, painful urination, or retention occurs5.
Last updated October 16, 2026. Read how we make monographs.
In the full monograph
38 sources, 24 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
- Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.
Sources
- 1Pygeum africanum for benign prostatic hyperplasia.pubmed.ncbi.nlm.nih.govWilt, Ishani, Mac Donald et al. · The Cochrane database of systematic reviews · 2002 · Pubmed
- 2Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.pubmed.ncbi.nlm.nih.govIshani, MacDonald, Nelson et al. · The American journal of medicine · 2000 · Pubmed
- 3[Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study].pubmed.ncbi.nlm.nih.govBarlet, Albrecht, Aubert et al. · Wiener klinische Wochenschrift · 1990 · Pubmed
- 4Oral Supplementation with l-Cystine, Serenoa repens, Cucurbita pepo, and Pygeum africanum in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study.pubmed.ncbi.nlm.nih.govPiquero-Casals, Saceda-Corralo, Aladren et al. · Skin appendage disorders · 2025 · Pubmed
- 5EMAema.europa.euEuropean Medicines Agency — European Union herbal monograph from the Committee on Herbal Medicinal Products (HMPC)
- 6Health Canadahealth-products.canada.caLabel statements and adult daily amounts Health Canada authorized on licensed natural health products with this ingredient alone, from the Licensed Natural Health Products Database. Contains information licensed under the Open Government Licence – Canada
- 7US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
- 8MSKCCmskcc.orgMemorial Sloan Kettering — About Herbs, Botanicals & Other Products
- 9Phytotherapy for benign prostatic hyperplasia.pubmed.ncbi.nlm.nih.govWilt, Ishani, Rutks et al. · Public health nutrition · 2000 · Pubmed
- 10[Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma].pubmed.ncbi.nlm.nih.govMorán, Budía, Broseta et al. · Actas urologicas espanolas · 2013 · Pubmed